Blair William & Co. IL Trims Stock Position in Danaher Corporation $DHR

Blair William & Co. IL cut its stake in shares of Danaher Corporation (NYSE:DHR) by 0.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,366,102 shares of the conglomerate’s stock after selling 9,622 shares during the period. Danaher accounts for approximately 0.7% of Blair William & Co. IL’s holdings, making the stock its 29th biggest holding. Blair William & Co. IL’s holdings in Danaher were worth $270,843,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter valued at about $26,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher in the 3rd quarter worth about $27,000. Howard Hughes Medical Institute purchased a new position in shares of Danaher in the 2nd quarter worth about $27,000. TruNorth Capital Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter worth about $31,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of DHR stock opened at $195.60 on Friday. The stock has a market capitalization of $138.32 billion, a price-to-earnings ratio of 38.81, a PEG ratio of 2.73 and a beta of 0.93. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80. The company’s 50-day simple moving average is $222.53 and its 200-day simple moving average is $215.93. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same quarter last year, the business posted $2.14 EPS. Danaher’s quarterly revenue was up 4.6% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.40 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s dividend payout ratio is presently 25.40%.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms recently issued reports on DHR. JPMorgan Chase & Co. increased their target price on shares of Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Evercore reaffirmed an “outperform” rating and set a $254.00 price target on shares of Danaher in a research report on Wednesday, January 28th. Guggenheim increased their price objective on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 2nd. TD Cowen reissued a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Finally, Jefferies Financial Group lifted their target price on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $253.86.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.